Karen Flynn

Karen is an accomplished healthcare leader with over 35 years of commercial, operations, and general management experience in the pharmaceutical services industry. She currently serves as Chief Commercial Officer of Catalent Pharma Solutions (NASDAQ: CTLT), a global provider of development and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. She previously served as the President of Catalent’s Biologics business. Prior to Catalent, she served as Senior Vice President and Chief Commercial Officer for West Pharmaceutical Services and as President of West’s Pharmaceutical Packaging Systems business. In addition to her experience leading high growth businesses, Karen brings an extensive background in commercial strategy, strategic planning, innovation, and quality management. She previously served on the Board of Directors of Recro Pharma, Inc., a specialty pharma and contract development and manufacturing organization focused on developing non-opioid products for acute pain and on solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development.